Article Details

PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering

Retrieved on: 2021-02-10 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

PureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public Offering. View article details on hiswai:

Excerpt

9, 2021 — Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up